Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Drugs used in pain management (1)
- Drugs used in pain management (2)
- Route of drug administration
- How to choose the right analgesic
- Acute pain
- Mechanism based
- Nociceptive vs. neuropathic pain
- Cancer pain
- WHO ladder for cancer pain
- Modified WHO ladder for cancer pain
- Absorption of fentanyl through the skin
- Evidence-based pain relief
- Comparison of different analgesics (1)
- Comparison of different analgesics (2)
- Interindividual variation of PTGS1 and PTGS2
- PTGS2 polymorphisms and analgesic response
- Interindividual variation in response to codeine
- Pharmacokinetics of codeine and morphine
- Tramadol
- Pharmacogenetics of analgesics
- Human mu opioid receptor gene SNPs
- NSAIDS & COXIBs
- Adverse effects of NSAIDs
- Endogenous opiates and behavior
- Nomenclature of opioid receptors
- Opioid receptor binding and activation
- Morphine and oxycodone in the brain and plasma
- Log octanol/water partition coefficients of opioids
- Pharmacokinetics of opioids (1)
- Transfer half-lives of opioids - plasma and brain
- Important half-lives of opioids
- Pharmacokinetics of opioids (2)
- Metabolism of oxycodone
- Oxycodone: CYP 3A4
- SEM plasma concentrations after oxycodone
- Equianalgesic doses
- Pharmacokinetics of methadone
- Elimination of methadone
- Methadone drug interactions
- Adverse effects of opioids
- Neuropathic pain
- Blocking sodium channels
- Treatment of neuropathic pain: Evidence of efficacy
- Antidepressants
- Neuropathic pain conditions: Antidepressants
- Mechanisms of action of antidepressants
- Drug interactions
- Ca++-channel modifiers as analgesics
- Gabapentinoids mechanism of action
- Gabapentinoids effects
- Neuropathic pain conditions: Gabapentinoids
- Sodium channel blockers as analgesics
- Mechanisms of action of anticonvulsants
- Topical analgesics
- Capsaicin
- New indications for "adjuvant" drugs
- Opioids in chronic non-cancer related pain (1)
- Opioids in chronic non-cancer related pain (2)
- Treatment duration
- Adverse effects
- Other concerns
- Combinations
- Tailoring treatment for the individual patient
- New targets
- Guidelines
Topics Covered
- Drugs used in pain management
- Drug administration
- Choosing the right analgesic
- Cancer pain
- Modified WHO ladder
- Opioid medication
- Inter-individual variation
- Pharmacokinetics and pharmacogenetics
- Adverse effects
- Half-lives of opioids
- Drug interactions
- How to treat adverse effects
- Neuropathic pain
- Anti-depressants
- Topical analgesics
- Adjuvant drugs
- Non-cancer pain
- Combinations of drugs
- New targets
- Guidelines
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kalso, E. (2010, February 25). Clinical pharmacology of pain [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/GKMG7267.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Eija Kalso has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.